IGXT (MC $50 M) NDA filing for MEGA thin-flim Cialis (better than Viagra) this month =10++ BAGGER Potential ! PLEASE read this guys and then join us to make big money .A LIFETIME OPPORTUNITY HERE GUYS !!!
2 US-NDA submission within 2 months ,lot of Cash and heavily underpriced at a valuation of just $50 million .1 Big drug partnered with Endo Pharma already under review by FDA market launch expected in 1H 2018 .GL
MarketCap $50 Million Cash ~$12 Million (including convertible debt) =cash untill 2021+ Price: 0.80
NDA submission for tadalafil (erectile dysfunction) thin-film version of Blockbuster drug Cialis in June or July NDA resubmission for Rizaport (migraine) in early Q3 Partnership for Tadalafil in 2H 2017
IntelGenx previously confirmed the bioequivalence of Tadalafil to Eli Lilly’s Cialis, which had sales of $1.5-billion in 2016 but faces generic competition in 2020. IntelGenx has an exclusive license for oral films from Lilly for its dosing patent, which would allow Tadalafil to enter the ED market in the U.S. free from patent litigation from Lilly. Dr. Matzen explains that Tadalafil, which offers a discrete dosing alternative, could enter the market in 2018, with up to three years of market exclusivity before Cialis is hit with generic competition.
Tadalafil is an erectile dysfunction (ED) treatment that boasts bioequivalence with Cialis, the current leading brand, and with a successful biostudy in-hand a 505(b)(2) NDA is set to be filed any day now, meaning that a full launch should be expected in mid-2018. Cialis is already winning-out over Viagra in terms of numbers of prescriptions, which is largely down to price and efficacy, but when Tadalafil comes to market with the same product in a more convenient and discreet delivery mechanism, IntelGenX should see a massive number of customers take-up its services.
IntelGenx has multi-faceted BD approach for its oral films
With a burgeoning pipeline of pharmaceutical oral films, IntelGenx’s (OTCQX:IGXT; TSXV:IGX) business development strategy is focused on partnering its product pipeline along with actively meeting with potential partners to explore manufacturing
MYOS, looks to be overvalued at this price Do you guys find it difficult to know when to buy or sell something? I prefer to get my stocks from awe.some.stock_s.
$5 is a reasonable price
The scenarios are quite interesting at current levels for MYOS. Not sure how awesome_stock.s finds all these incredible trade ideas but im happy.
Who says MYOS isn't poised for potentially massive upward movement? Yo you should really check out awe.some.stock.s, they seem on point with their stocks.
Very difficult to see MYOS not making a big run north. google awesomeS-TOCKS - they offer pretty good trade alerrts. you dont have to trade their tickers but it definetly helps you recognize possible patterns for stocks you're trading.
another tanker underway...
So what's the reason for this climbing? No news and yet... share your thoughts, got 1000 for 2.3
almost 10% up? wonder what is going on
Should I stay or should I go now....🤔
Now it's a good price. Buying 2000shares and holding to Q3
I don't really understand the rights plan. Any help out there
Any recent news, the stock has been floating between 2 and 3 and is still a bit undervalued in my opinion.
Product release today, any thoughts on how that will affect the price? I assume it will pump a bit.
Who else got the top-market/gainer alert this morning?
Just got an alert for this stock today. It has been on my watchlist for a while so I'm in at this low price
reach $4.20 sold if luck otherwise that about it, $3.85 that highest of the day, crazy buy, tried jump in but the price went up like sky rock now what it went down...how about that?